Coya Therapeutics Inc (COYA)

Finanzdaten der Coya Therapeutics Inc-Aktie (COYA)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	97.89% 0.1268	6.0022	-	-	-
Operating Expenses	33.98% 5.6098	4.1871	3.5641	3.2543	2.9001
Benefits Costs and Expenses	5.1788	-	-	-	-
Costs And Expenses	5.1788	-	-	-	-
Operating Income/Loss	402.07% -5.483	1.8152	-3.5641	-3.2543	-2.9001
Income/Loss From Continuing Operations Before Tax	353.89% -5.0519	1.9898	-3.422	-3.0954	-2.7365
Income/Loss From Continuing Operations After Tax	499.05% -5.0519	1.266	-3.422	-3.0954	-2.7365
Net Income/Loss	499.05% -5.0519	1.266	-3.422	-3.0954	-2.7365
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	4,878% 14.46	0.2905	9.9479	9.9479	9.7218
Diluted Average Shares	4,878% 14.46	0.2905	9.9479	9.9479	9.7218
Basic Earnings Per Share	333.33% -0.35	0.15	-0.34	-0.31	-0.28
Diluted Earnings Per Share	333.33% -0.35	0.15	-0.34	-0.31	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-